180 related articles for article (PubMed ID: 24289849)
1. The inhibitory role of Mir-29 in growth of breast cancer cells.
Wu Z; Huang X; Huang X; Zou Q; Guo Y
J Exp Clin Cancer Res; 2013 Dec; 32(1):98. PubMed ID: 24289849
[TBL] [Abstract][Full Text] [Related]
2. miR-29a suppresses MCF-7 cell growth by downregulating tumor necrosis factor receptor 1.
Zhao Y; Yang F; Li W; Xu C; Li L; Chen L; Liu Y; Sun P
Tumour Biol; 2017 Feb; 39(2):1010428317692264. PubMed ID: 28222663
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
[TBL] [Abstract][Full Text] [Related]
4. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
Zhong S; Li W; Chen Z; Xu J; Zhao J
Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196
[TBL] [Abstract][Full Text] [Related]
5. miR-29a contributes to breast cancer cells epithelial-mesenchymal transition, migration, and invasion via down-regulating histone H4K20 trimethylation through directly targeting SUV420H2.
Wu Y; Shi W; Tang T; Wang Y; Yin X; Chen Y; Zhang Y; Xing Y; Shen Y; Xia T; Guo C; Pan Y; Jin L
Cell Death Dis; 2019 Feb; 10(3):176. PubMed ID: 30792382
[TBL] [Abstract][Full Text] [Related]
6. ErbB2 down-regulates microRNA-205 in breast cancer.
Adachi R; Horiuchi S; Sakurazawa Y; Hasegawa T; Sato K; Sakamaki T
Biochem Biophys Res Commun; 2011 Aug; 411(4):804-8. PubMed ID: 21787752
[TBL] [Abstract][Full Text] [Related]
7. Crucial role for early growth response-1 in the transcriptional regulation of miR-20b in breast cancer.
Li D; Ilnytskyy Y; Kovalchuk A; Khachigian LM; Bronson RT; Wang B; Kovalchuk O
Oncotarget; 2013 Sep; 4(9):1373-87. PubMed ID: 23945289
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of microRNA-29a Changes the Expression of Heat Shock Proteins in Breast Carcinoma MCF-7 Cells.
Choghaei E; Khamisipour G; Falahati M; Naeimi B; Mossahebi-Mohammadi M; Tahmasebi R; Hasanpour M; Shamsian S; Hashemi ZS
Oncol Res; 2016 Jan; 23(1-2):69-78. PubMed ID: 26802653
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-148a promotes apoptosis and suppresses growth of breast cancer cells by targeting B-cell lymphoma 2.
Li Q; Ren P; Shi P; Chen Y; Xiang F; Zhang L; Wang J; Lv Q; Xie M
Anticancer Drugs; 2017 Jul; 28(6):588-595. PubMed ID: 28430743
[TBL] [Abstract][Full Text] [Related]
10. Suppressing the molecular signaling pathways involved in inflammation and cancer in breast cancer cell lines MDA-MB-231 and MCF-7 by miR-590.
Sheikholeslami A; Nabiuni M; Arefian E
Tumour Biol; 2017 Apr; 39(4):1010428317697570. PubMed ID: 28443471
[TBL] [Abstract][Full Text] [Related]
11. p12(CDK2-AP1) inhibits breast cancer cell proliferation and in vivo tumor growth.
Zhou W; Guan X; Wang L; Liao Y; Huang J
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2085-93. PubMed ID: 22828875
[TBL] [Abstract][Full Text] [Related]
12. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis.
Singh B; Ronghe AM; Chatterjee A; Bhat NK; Bhat HK
Carcinogenesis; 2013 May; 34(5):1165-72. PubMed ID: 23492819
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells.
Sun FD; Wang PC; Luan RL; Zou SH; Du X
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1342-1350. PubMed ID: 29565492
[TBL] [Abstract][Full Text] [Related]
15. miR-29a regulated ER-positive breast cancer cell growth and invasion and is involved in the insulin signaling pathway.
Li ZH; Xiong QY; Xu L; Duan P; Yang QO; Zhou P; Tu JH
Oncotarget; 2017 May; 8(20):32566-32575. PubMed ID: 28427228
[TBL] [Abstract][Full Text] [Related]
16. Negative regulation of CDC42 expression and cell cycle progression by miR-29a in breast cancer.
Zhang M; Guo W; Qian J; Wang B
Open Med (Wars); 2016; 11(1):78-82. PubMed ID: 28352771
[TBL] [Abstract][Full Text] [Related]
17. CircACAP2 promotes breast cancer proliferation and metastasis by targeting miR-29a/b-3p-COL5A1 axis.
Zhao B; Song X; Guan H
Life Sci; 2020 Mar; 244():117179. PubMed ID: 31863774
[TBL] [Abstract][Full Text] [Related]
18. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation.
Yu Z; Wang C; Wang M; Li Z; Casimiro MC; Liu M; Wu K; Whittle J; Ju X; Hyslop T; McCue P; Pestell RG
J Cell Biol; 2008 Aug; 182(3):509-17. PubMed ID: 18695042
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer.
Sandhu R; Rivenbark AG; Mackler RM; Livasy CA; Coleman WB
Int J Oncol; 2014 Feb; 44(2):563-72. PubMed ID: 24297604
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-29a inhibits proliferation and motility of schwannoma cells by targeting CDK6.
Ma J; Li T; Yuan H; Han X; Shui S; Guo D; Yan L
J Cell Biochem; 2018 Mar; 119(3):2617-2626. PubMed ID: 29023945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
